Viewing Study NCT00867061


Ignite Creation Date: 2025-12-24 @ 11:59 AM
Ignite Modification Date: 2026-02-26 @ 11:14 AM
Study NCT ID: NCT00867061
Status: WITHDRAWN
Last Update Posted: 2017-06-23
First Post: 2009-03-19
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy and Safety of 5-day Dosing of ON 01910.Na in Intermediate-1,-2, or High Risk Myelodysplastic Syndrome (MDS)
Sponsor: Traws Pharma, Inc.
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: Onconova 04-11
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators